AstraZeneca Up, Puma Rises, Greggs Rallies

On this episode of Stock Movers:
- AstraZeneca rose along with other pharmaceutical companies after Pfizer secured a reprieve from President Donald Trump’s long-threatened tariffs by agreeing to slash some of its drug prices.
- Puma shares climbed after Nike reported better than expected sales, signalling an upbeat in demand for sportswear.
- Greggs marked the biggest jump in shares since 2021 after it said trading improved in August and September.

See omnystudio.com/listener for privacy information.